Clinical Disorder Treatment Market Size

Clinical Disorder Treatment Market size is poised to witness over 6.3% CAGR during the forecast period i.e., between 2024-2036. The growth of the market can be attributed to the increasing prevalence of psychiatric and psychological disorders, and rising cases of substance abuse among adolescents around the world. According to a statistical report titled Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017), as of 2017, 264 million people were affected by depression, whereas, dementia affected nearly 50 million people globally. Along with these, mounting need for effective management of anxiety and depression related disorders is also expected to drive market growth in the coming years. Furthermore, many hospitals, clinics and health institutions are organizing campaigns to create awareness about relevant treatment options for clinical disorders among general public. This in turn is projected to offer abundant growth opportunities to the clinical disorder treatment market in the near future.

Frequently Asked Questions (FAQ)

Clinical Disorder Treatment Market size is poised to witness over 6.3% CAGR during the forecast period i.e., between 2024-2036.

The market growth is driven by increasing prevalence of psychiatric and psychological disorders, and rising cases of substance abuse among adolescents worldwide.

Asia Pacific industry is expected to hold largest revenue share by 2036, ascribed to growing incidences of substance abuse among teenagers and adults, especially in India and China, and increasing prevalence of clinical disorders in the region.

The major players in the market are Universal Health Services, Inc., CareTech Holdings PLC, Behavioral Health Network, Inc., Pfizer Inc., and others.

Clinical Disorder Treatment Market Size